Entin and Waxman Quoted on Fraud and Abuse Among Health Law Issues
04 January 2007
Health Law Reporter
Reproduced with permission from BNA’s Health Law Reporter, Vol. 16, No. 1, pp. 5-16 (Jan. 4, 2007). Copyright 2007 by The Bureau of National Affairs, Inc. (800-372-1033) <http://www.bna.com>
Related News
13 February 2025
In the News
Nikhil Pradhan on FDA Draft AI Drug Guidance – 'The industry is very much evolving'
Foley & Lardner LLP senior counsel Nikhil Pradhan shared insight on recent draft guidance from the U.S. Food and Drug Administration's in the MedCentral article, "FDA Draft Guidance Addresses Drug Submissions that Use AI Data."
12 February 2025
In the News
Carrie Hoffman Quoted on Federal Arbitration Act's Transportation Exemption
11 February 2025
In the News
Foley Attorneys on CFPB Shutdown – Industry in 'wait-and-see mode'
Foley & Lardner LLP attorneys Christi Lawson, Natasha Dempsey, and Whitney Nicholas assessed the Trump administration's curtailment of the Consumer Financial Protection Bureau (CFPB) in the Newsweek article, "What CFPB Shutdown Means for Junk Fees."